Breaking News

Regeneron CEO admits some regret over interview; BioNTech's CEO on the future of personalized medicine

 

Pharmalot Ed Silverman

STAT+: Regeneron's George Yancopoulos admits some regret, but 'I don't apologize'

By Jason Mast

Mike Coppola/Getty Images for Klick Health

George Yancopoulos acknowledged he could’ve handled things differently after getting booed on stage last month over Alzheimer’s drug remarks.

Read More

STAT+: BioNTech CEO lays out vision for how mRNA and AI can power personalized medicine

By Jonathan Wosen

JASPER JACOBS/BELGA MAG/AFP via Getty Images

With the acquisition of machine learning firm InstaDeep, BioNTech is betting that AI will play a key role in the future of mRNA medicines.

Read More

STAT+: Medicare paves the way for CAR-T in doctors offices

By John Wilkerson

Adobe

Medicare officials have taken a step toward making a cutting-edge cancer treatment called CAR-T cell therapy available in doctor offices.

Read More

Opinion: Democratizing drug development will be a win for all

By Vanessa Almendro

MANDEL NGAN/AFP via Getty Images

New tools are putting the drug development process within reach of a broader population of scientists — and even nonscientists.

Read More

Thursday, January 12, 2023

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2023, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments